In Bonnie Steinbock (ed.), The Oxford Handbook of Bioethics. Oxford University Press (2009)

Allen Buchanan
University of Arizona
While acknowledging the potential benefits of pharmacogenomics as a methodology, a number of comprehensive reports in the past several years examine a multitude of ethical, legal, and social factors that may limit the extent to which these benefits are realized — and realized in ethically acceptable ways. This article aims to identify and explore the most basic ethical and regulatory issues that are likely to arise if pharmacogenomics becomes widely enough used to have a significant impact on research and clinical practice. First, however, it addresses the question of whether pharmacogenomic tests are unique when compared to other genetic tests and thus deserving of more or less stringent ethical and regulatory requirements.
Keywords No keywords specified (fix it)
Categories (categorize this paper)
Buy the book Find it on
DOI 10.1093/oxfordhb/9780199562411.003.0024
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

PhilArchive copy

Upload a copy of this paper     Check publisher's policy     Papers currently archived: 62,513
External links

Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
Through your library

References found in this work BETA

No references found.

Add more references

Citations of this work BETA

Add more citations

Similar books and articles

Pharmacogenomics, Ethics, and Public Policy.Karen Peterson-Iyer - 2008 - Kennedy Institute of Ethics Journal 18 (1):pp. 35-56.
Ontological Issues in Pharmacogenomics.Russ B. Altman - 2007 - The Monist 90 (4):523-533.
Pharmacogenomics: Social, Ethical, and Clinical Dimensions.A. Hedgecoe - 2004 - Journal of Medical Ethics 30 (6):e6-e6.
Innovative Surgery: The Ethical Challenges.Jane Johnson & Wendy Rogers - 2012 - Journal of Medical Ethics 38 (1):9-12.
The Troubling Persistence of Race in Pharmacogenomics.Jonathan Kahn - 2012 - Journal of Law, Medicine and Ethics 40 (4):873-885.


Added to PP index

Total views
23 ( #471,193 of 2,446,442 )

Recent downloads (6 months)
1 ( #456,581 of 2,446,442 )

How can I increase my downloads?


My notes